Sign in

CIK 0001684144 · Non-accelerated filer<br>Smaller reporting company

Zomedica Corp.

Sign in to watch
Ticker
ZOMDF
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Alberta, Canada
Entity type
operating
Phone
(734) 369-2555
Business address
1101 TECHNOLOGY DRIVE, SUITE 100, ANN ARBOR, MI, 48108
Former names
Zomedica Pharmaceuticals Corp.
  1. 4 Open-market buy COO bought 100,000 shares at $0.14 ($14,200)
  2. 4 Open-market buy Vice President of Sales bought 299,993 shares at $0.16 ($46,529)
  3. 4 Open-market buy Vice President of Sales bought 700,007 shares at an average $0.15 ($105,041)
  4. 4 Open-market buy Chief Financial Officer bought 25,000 shares at $0.15 ($3,798)
  5. 4 Open-market buy Director bought 100,000 shares at an average $0.17 ($17,450)
  6. 4 Open-market buy Director bought 25,000 shares at $0.18 ($4,600)
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy Director bought 50,000 shares at an average $0.14 ($6,981)
  9. 4 Open-market buy Director bought 100,000 shares at $0.14 ($14,000)
  10. 4 Open-market buy COO bought 150,000 shares at $0.14 ($21,000)
  11. 4 Open-market buy CEO bought 100,000 shares at $0.14 ($14,200)
  12. 4/A Open-market buy Director bought 100,000 shares at $0.17 ($16,500)
  13. 4 Open-market buy Director bought 100,000 shares at $0.17 ($16,500)
  14. 4 Open-market buy Director bought 100,000 shares at $0.17 ($16,600)
  15. 4 Open-market buy CEO bought 100,000 shares at $0.17 ($16,600)
  16. 4 Open-market buy Director bought 150,000 shares at $0.17 ($25,950)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Open-market buy CEO bought 100,000 shares at $0.19 ($19,090)

Page 4 of 10 · 183 filings